CGREF1 and fatty liver disease: Having found the increased tendency of developing T2DM symptoms such as elevated blood glucose and NEFA levels in WT mice with normal Cgref1 expression, as well as other evidence showing impaired glucose homeostasis (Figure 4D-F and Figure 5A-C), it was reasonable to acknowledge that WT mice would bear higher risks of acquiring hepatic steatosis.